|
KMID : 0980320190190060343
|
|
Journal of Dental Anesthesia and Pain Medicine
2019 Volume.19 No. 6 p.343 ~ p.351
|
|
|
Effects of remifentanil preconditioning on factors related to uterine contraction in WISH cells
|
|
Kim Cheul-Hong
Lee Sang-Hoon
Kim Eun-Jung
Ahn Ji-Hye
Choi Eun-Ji
Yoon Ji-Uk
Choi In-Seok
|
|
|
Abstract
|
|
|
Background: Preterm labor and miscarriage may occur in stressful situations, such as a surgical operation or infection during pregnancy. Pharyngeal and buccal abscess and facial bone fractures are inevitable dental surgeries in pregnant patients. Remifentanil is an opioid analgesic that is commonly used for general anesthesia and sedation. Nonetheless, no study has investigated the effects of remifentanil on amniotic epithelial cells. This study evaluated the effects of remifentanil on the factors related to uterine contraction and its mechanism of action on amniotic epithelial cells.
Methods: Amniotic epithelial cells were preconditioned at various concentrations of remifentanil for 1 h, followed by 24-h lipopolysaccharide (LPS) exposure. MTT assays were performed to assess the cell viability in each group. The effects of remifentanil on factors related to uterine contractions in amniotic epithelial cells were assessed using a nitric oxide (NO) assay, western blot examinations of the expression of nuclear factor-kappa B (NF-κB), cyclooxygenase 2 (COX2), and prostaglandin E2 (PGE2), and RT-PCR examinations of the expression of the proinflammatory cytokines interleukin (IL)-1β and tumor necrosis factor-alpha (TNF-α).
Results: Remifentanil did not affect viability and nitric oxide production of amniotic epithelial cells. Western blot analysis revealed that remifentanil preconditioning resulted in decreased expressions of NF-κB and PGE2 in the cells in LPS-induced inflammation, and a tendency of decreased COX2 expression. The results were statistically significant only at high concentration. RT-PCR revealed reduced expressions of IL-1β and TNF-α.
Conclusions: Preconditioning with remifentanil does not affect the viability of amniotic epithelial cells but reduces the expression of factors related to uterine contractions in situations where cell inflammation is induced by LPS, which is an important inducer of preterm labor. These findings provide evidence that remifentanil may inhibit preterm labor in clinical settings.
|
|
|
KEYWORD
|
|
|
Amniotic Epithelial Cells, Lipopolysaccharides, NF-kappa B, Preterm Labor, Remifentanil, Uterine Contraction
|
|
|
FullTexts / Linksout information
|
|
  
|
|
|
Listed journal information
|
|
|
|